Frankfurt - Delayed Quote • EUR Stryker Corporation (SYK.F) Follow Compare 371.40 +1.90 +(0.51%) At close: January 17 at 5:46:00 PM GMT+1 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc. Portage, Michigan, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purchase all of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: NARI) for $80.00 per share in cash. The offer is being made pursuant to the previously announced merger agreement, dated as of January 6, 2025, among Stryker, Eagle 1 Merger Sub, Inc and Inari. The tender o Stryker Corporation (SYK): A Bull Case Theory We came across a bullish thesis on Stryker Corporation (SYK) on Business Model Mastery’s Substack by The Antifragile Investor. In this article, we will summarize the bulls’ thesis on SYK. Stryker Corporation (SYK)’s share was trading at $360.98 as of Jan 13th. SYK’s trailing and forward P/E were 38.69 and 26.74 respectively according to Yahoo Finance. Stryker […] Stryker Had A Good Year Last Year; Here's How It's Looking For 2025 Medical products maker Stryker reported double-digit profit growth every quarter this past year, and double digit revenue growth in all-but-one of those quarters. On Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74. The upgraded 74 RS Rating shows that Stryker topped 74% of stocks for price performance over the past year. Here’s Why Jim Cramer Is Excited About Stryker (SYK) Expanding Beyond Surgical Robotics We recently published a list of Jim Cramer Discussed These 18 Stocks After Major AI Event. In this article, we are going to take a look at where Stryker Corporation (NYSE:SYK) stands against other stocks that Jim Cramer discussed after major AI event. After the Consumer Electronics Show (CES) in Las Vegas, Jim Cramer had […] Is Inari Medical Inc. (NARI) Firm Posts Strong Gain Amid Wall Street Bloodbath? We recently published a list of 10 Firms Post Strong Gains Amid Wall Street Bloodbath. In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against other firms post strong gains amid Wall Street bloodbath. Wall Street’s main indices closed sharply in the red on Tuesday, as investors […] PAHC or SYK: Which Is the Better Value Stock Right Now? PAHC vs. SYK: Which Stock Is the Better Value Option? Stryker’s Strategic Acquisition of Inari Medical Announced Stryker ( (SYK) ) has provided an announcement. Stryker Corporation has announced a definitive agreement to acquire Inari Medical, Inc. for $80 per share, with a total equity value of approximately $4.9 billion. This acquisition is set to enhance Stryker’s position in the peripheral vascular segment, expanding its portfolio with Inari’s innovative solutions for venous thromboembolism, complementing Stryker’s existing Neurovascular business. The transaction, expected to close by the first quarter Inari Medical Catapults — Again — After Stryker Confirms $4.9 Billion Deal Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion. Inari stock catapulted Tuesday on the news. Stryker's $4.9B Power Move: Why This MedTech Giant Just Changed the Game The bold acquisition of Inari Medical unlocks a $10B market and reshapes the future of vascular care. Stryker Stock Falls Despite the Agreement to Acquire Inari Medical SYK inks an agreement to acquire Inari Medical at a valuation of approximately $4.9 billion. Inari Medical Jumps 22% as Stryker Confirms $4.9B Acquisition Deal with 60% Premium Stryker to acquire Inari Medical for $80/share, boosting its vascular treatment portfolio with innovative technologies Stryker Buying Inari Medical in $4.9B Deal to Boost Vascular Business Inari’s product portfolio should align well with Stryker’s Neurovascular business. 5 Things to Know Before the Stock Market Opens News of the day for Jan. 7, 2025 Inari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9B Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after the bell Monday. Inari Medical (NARI) Soars 30.6%: Is Further Upside Left in the Stock? Inari Medical (NARI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road. Stryker to Buy Inari Medical in $4.9 Billion Deal Stryker (SYK) agreed to acquire medical technology maker Inari Medical (NARI) in an all-cash deal wo Inari Medical soars on Stryker acquisition Investing.com -- Inari Medical Inc (NASDAQ:NARI) shares surged sharply after Stryker (NYSE:SYK) announced that it would acquire the medical device maker in an all-cash deal valued at $4.9 billion Stryker agrees to acquire Inari Medical for $4.9bn The acquisition is expected to be finalised by the end of this year’s first quarter. Update: Stryker to Acquire Inari Medical for $4.9 Billion to Expand Peripheral Vascular Portfolio (Updates to include analyst comments in the sixth and seventh paragraphs, as well as the recent stoc Ulta, Meta, Stryker and Inari Medical: After-Hours Movers In today’s Asking for a Trend update, host Josh Lipton covers several top stocks making moves in the after-hours trading session. Ulta Beauty (ULTA) shares rise after announcing CEO Dave Kimball’s retirement and a stronger-than-expected holiday season. Meta Platforms (META) makes headlines by adding UFC CEO and President Dana White and other high-profile leaders to its board. Stryker (SYK) moves to acquire Inari Medical (NARI) for $4.9 billion to strengthen its portfolio of neurovascular treatments. To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here. This post was written by Josh Lynch Performance Overview Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return SYK.F S&P 500 YTD +5.91% +1.52% 1-Year +29.78% +25.82% 3-Year +67.44% +28.61%